Determining the association between fibromyalgia, the gut microbiome and its biomarkers: A systematic review

• Main Authors: Sharon Erdrich, Jason A. Hawrelak, Stephen P. Myers, Joanna E. Harnett
• Format: Article
• Language: English
• Published: BMC 2020-03-01
• Series: BMC Musculoskeletal Disorders
• Subjects: Fibromyalgia; Fibromyalgia syndrome; Gastrointestinal microbiome; Biomarkers; Systematic review
• Online Access: http://link.springer.com/article/10.1186/s12891-020-03201-9

Abstract Background The association between fibromyalgia and irritable bowel syndrome is well-established. Alterations in the composition and diversity of the gut microbiome in irritable bowel syndrome have been reported, however, this association is poorly understood in fibromyalgia. Our aim was to summarise the research reporting on the gastrointestinal microbiome and its biomarkers in people with fibromyalgia. Methods A systematic review of published original research reporting on the gastrointestinal microbiota and its biomarkers in adults with a diagnosis of fibromyalgia was undertaken. Results From 4771 studies, 11 met our inclusion criteria and were separated into four main groups: papers reporting Helicobacter pylori; other gut bacterial markers; metabolomics and other biomarkers, which included intestinal permeability and small intestinal bacterial overgrowth. Conclusion The results suggest there is a paucity of quality research in this area, with indications that the gut microbiota may play a role in fibromyalgia within the emerging field of the gut-musculoskeletal axis. Further investigations into the relationship between the gut microbiota, gut dysfunction and fibromyalgia are warranted.